News provided by Novo Nordisk Nov 17, 2025, 07:45 ET For a limited time, patients in the US can get the first two doses of authentic, FDA-approved Wegovy and Ozempic for only $199 each beginning November 17, 2025 Also effective November 17, Novo Nordisk is lowering the price of Wegovy and Ozempic for existing self-pay patients in the US from $499 to $349 per month* Self-pay pricing available through 70,000+ pharmacies nationwide, home delivery, and select telehealth providers These offers build on Novo Nordisk's ongoing efforts to expand access to FDA-approved semaglutide medicines across the many different channels patients use to get their prescriptions PLAINSBORO, N.J., Nov
In a letter to the National Association of Boards of Pharmacy the FDA wrote: We also wish to ensure you are aware that the active pharmaceutical ingredient in Wegovy and Ozempic is semaglutide in its base form
Watch for symptoms of hypoglycemia, especially in the hours following injection
Important remind: A higher dose is NOT always better
The researchers also found that the benefits of GLP-1 therapy were especially pronounced in older adults, women, and certain racial subgroups